Cloetta AB (publ)

Cloetta AB (publ) operates as a confectionary company. It manufactures and markets chocolate confectionery products, including pralines, chocolate wafers, dragees, plates, and countlines under the Kexchoklad, Polly, Center, Plopp, Tupla, Royal, Sportlunch, Bridge, Lonka, Sinas, Snippers, and Lonka soft nougat brands. The company also provides confectionery products comprising foams, wine gums, liquorice, toffees, hard boiled candies, and lollypops under the Malaco, Red Band, Ahlgrens bilar, Venco, Chewits, and Juleskum brands. In addition, it offers pastilles under the Läkerol, Mynthon, and King brands, as well as chewing gums under the Jenkki, Sportlife, and Xylifresh brands. Further, the company produces and sells dry roasted nuts under the Nutisal brand. It sells its products through a network of grocery retail trade, service trade, e-commerce, and other sales channels. Cloetta AB (publ) was founded in 1862 and is headquartered in Sundbyberg, Sweden.

Cloetta AB (publ) trades as CLOEF on OTC. The company is classified in Consumer Defensive / Food Confectioners and reports in USD.

The current profile places the business in Food Confectioners. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Cloetta AB (publ) can be compared against peers such as Hilton Food Group plc, Jamieson Wellness Inc., Lassonde Industries Inc., The SPAR Group Ltd, The SPAR Group Ltd, Scandinavian Tobacco Group A/S.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1.51B, beta of 0.67, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CLOEF currently shows total debt of N/A and beta of 0.67. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.cloetta.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.